Results 191 to 200 of about 397,364 (338)
ABSTRACT Gastrointestinal defects and immunodeficiency syndrome 1 (GIDID1) is a rare autosomal recessive disorder caused by biallelic variants in TTC7A. GIDID1 is characterized by a broad clinical spectrum ranging from very early‐onset inflammatory bowel disease (VEOIBD) to multiple intestinal atresia (MIA) with or without immunological manifestations.
Julia Imhoff+8 more
wiley +1 more source
Metabolic alterations in human pulmonary artery smooth muscle cells treated with PDGF‐BB
Metabolic abnormalities are considered to play a key regulatory role in vascular remodeling of pulmonary arterial hypertension. We analyzed the metabolome in the culture supernatants of human pulmonary artery smooth muscle cells (PASMC) during the malignant proliferation phenotype transition via a targeted metabolomics method. Significant and extensive
Meng‐Jie Zhang+9 more
wiley +1 more source
Pulmonary fibrosis: from mechanisms to therapies. [PDF]
Jiang M+11 more
europepmc +1 more source
The Effect of Indomethacin on the Bleomycin-Induced Pulmonary Fibrosis in the Rats [PDF]
Dong Soon Kim+3 more
openalex +1 more source
Schematic diagram of the mechanism of DEK regulating RhoA activation Ezrin. Upon house dust mite (HDM) stimulation, HDM‐specific immunoglobulin E (IgE) and inflammatory factors such as interleukin 4 (IL‐4), IL‐5, IL‐13, and eosinophils increased in the nasal mucosa.
Longzhu Dai+8 more
wiley +1 more source
Pyroptosis-related signatures predict immune characteristics and prognosis in IPF
The purpose of this work was to use integrated bioinformatics analysis to screen for pyroptosis-related genes (PRGs) and possible immunological phenotypes linked to the development and course of IPF.
Yijun He+13 more
doaj
Idiopathic Pulmonary Fibrosis: Correlations between Bronchoalveolar Cellular Constituents and the Pathologic, Physiologic and Radiographic Features and Response to Treatment [PDF]
S. H. Cho+9 more
openalex +1 more source
Demystifying pulmonary fibrosis [PDF]
openaire +2 more sources
Grafts used to construct lung cancer animal models come from various sources, primarily cell lines, patient‐derived tumor tissues, and circulating tumor cells. Based on the sources of grafts and research objectives, lung cancer animal models can be categorized into several types: chemical‐induced models, orthotopic transplantation models, heterotopic ...
Zixuan Yang+7 more
wiley +1 more source
Background: Cystic fibrosis (CF) is associated with dysregulated immune responses, exaggerated inflammation and chronic infection. CF transmembrane conductance regulator (CFTR) modulator therapies directly target the underlying protein defects and ...
Dirk Westhölter+8 more
doaj